| scholarly article | Q13442814 |
| P50 | author | John B. Furness | Q42732057 |
| Belinda S. Parker | Q53679448 | ||
| Thomas Reinheckel | Q56849298 | ||
| Daniel Edgington-Mitchell | Q60151689 | ||
| Matthew Bogyo | Q87128638 | ||
| Laura E. Edgington | Q41183551 | ||
| P2093 | author name string | Nigel W Bunnett | |
| Bim Graham | |||
| Vasilena Gocheva | |||
| Peter Storz | |||
| Johanna A Joyce | |||
| TinaMarie Lieu | |||
| Martijn Verdoes | |||
| Wouter A van der Linden | |||
| Nimali P Withana | |||
| Thomas Wartmann | |||
| Walter Halangk | |||
| Luigi Aurelio | |||
| Alicia K Fleming | |||
| P2860 | cites work | The asparaginyl endopeptidase legumain after experimental stroke | Q42575403 |
| Distinct protease requirements for antigen presentation in vitro and in vivo. | Q43158650 | ||
| Legumain expression as a prognostic factor in breast cancer patients. | Q44014299 | ||
| Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. | Q44103830 | ||
| Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity | Q44104053 | ||
| Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice. | Q46499913 | ||
| Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. | Q51056982 | ||
| Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer. | Q54317876 | ||
| Acute pancreatitis | Q55967029 | ||
| Acute pancreatitis | Q56094875 | ||
| High expression of the cysteine proteinase legumain in colorectal cancer – Implications for therapeutic targeting | Q56965662 | ||
| Edema and intrapancreatic trypsinogen activation precede glutathione depletion during caerulein pancreatitis | Q71404575 | ||
| Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats | Q74831729 | ||
| Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis | Q79856720 | ||
| Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer | Q80317628 | ||
| CCL2-induced migration and SOCS3-mediated activation of macrophages are involved in cerulein-induced pancreatitis in mice | Q83252742 | ||
| Structure and function of legumain in health and disease | Q26781444 | ||
| Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation | Q27678659 | ||
| Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice | Q28513876 | ||
| Role of macrophages in the progression of acute pancreatitis | Q33902198 | ||
| Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer | Q34406043 | ||
| Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection | Q34620078 | ||
| Targeting tumor-associated macrophages as a novel strategy against breast cancer | Q34803221 | ||
| Expression of legumain correlates with prognosis and metastasis in gastric carcinoma | Q34984213 | ||
| Development of near-infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain | Q35567972 | ||
| Functional imaging of legumain in cancer using a new quenched activity-based probe | Q35600638 | ||
| Active cathepsins B, L, and S in murine and human pancreatitis | Q36312705 | ||
| Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer | Q36413686 | ||
| Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer | Q36480910 | ||
| Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma | Q36810574 | ||
| Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs. | Q37071752 | ||
| Improved quenched fluorescent probe for imaging of cysteine cathepsin activity | Q37304778 | ||
| Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis | Q39017137 | ||
| Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile. | Q40247139 | ||
| Development of activity-based probes for trypsin-family serine proteases | Q40301031 | ||
| Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis | Q40735691 | ||
| In vivo imaging and biochemical characterization of protease function using fluorescent activity-based probes | Q41808773 | ||
| Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice. | Q42273053 | ||
| Essential role of monocytes and macrophages in the progression of acute pancreatitis | Q42478797 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P304 | page(s) | G548-60 | |
| P577 | publication date | 2016-08-11 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Legumain is activated in macrophages during pancreatitis | |
| P478 | volume | 311 |
| Q99712025 | Adipose Tissue Properties in Tumor-Bearing Breasts |
| Q64892923 | Legumain Promotes Atherosclerotic Vascular Remodeling. |
| Q92358245 | Legumain Promotes Gastric Cancer Progression Through Tumor-associated Macrophages In vitro and In vivo |
| Q40050488 | Transcriptome profiling of antiviral immune and dietary fatty acid dependent responses of Atlantic salmon macrophage-like cells |
Search more.